DRA SearchDRASearch

  • Search Home
  • DRA Home

ERX3308142

FASTQ

SRA

Experiment Detail

TitleIllumina HiSeq 2500 paired end sequencing; ATAC-seq of primary mammalian aortic endothelial cells before and after TNFα stimulation
Design DescriptionATAC-seq of primary mammalian aortic endothelial cells before and after TNFα stimulation
OrganismMus musculus

Library Description

NameMAEC_ATAC_control_biorep_1_p
StrategyATAC-seq
SourceGENOMIC
SelectionPCR
LayoutPAIRED
Orientation
Nominal Length510
Nominal Sdev228
Construction ProtocolPrimary aortic endothelial cells (ECs) isolated from human aorta (HAECs: two 21 year old Caucasian males), mouse aorta (MAECs: two biological replicates of C57BL/6 males from pooled mice), and bovine aorta (BAEC: two biological replicates) were grown in cell culture. Cells were cultured at 37°C and 5% CO2 supplied with Endothelial Cell Growth Media MV2 (PromoCell) supplemented with 5% fetal calf serum (PromoCell), 5 ng/ml recombinant human epidermal growth factor (PromoCell), 0.5 ng/ml recombinant human vascular endothelial growth factor 165 (PromoCell), 10 ng/ml recombinant human basic fibroblast growth factor (PromoCell), 20 ng/ml long R3 insulin-like growth factor-1 (PromoCell), 1 μg/ml ascorbic acid (PromoCell) and 0.2 μg/ml hydrocortisone (PromoCell). All experiments were carried out before passage 9. HAECs were treated with 10 ng/mL recombinant human TNFα (Cell Applications, cat# RP1111-50), MAECs were treated with 10 ng/mL recombinant mouse TNFα (Cell Applications, cat# RP2031-20), and BAECs were treated with 10 ng/mL recombinant bovine TNFα (R&D Systems, cat# 2279-BT-025) for 45 mins in basal Endothelial Cell Growth Media MV2 (PromoCell) without supplements. The un-stimulated control samples were treated with vehicle (water). ~50K cells were harvested from each biological replicate of un-stimulated and TNF-α stimulated (45 min. 10 ng/ml) HAECs (#1487 and #2139), MAECs (#A092913T2MP and #B092913T2MP), and BAECs (#1165 and #1190). Cells were lysed in nonionic detergent lysis buffer (10 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 10 mM NaCl, 0.1% NP-40) for nuclei isolation. The nuclei were pelleted and re-suspended in 50 ul transposition reaction solution of 2.5 ul transposome complex containing Tn5 transposase attached to sequencing adapters (Illumina Nextera Tagment DNA enzyme TDE1, Nextera® DNA Sample Preparation Kit cat# FC-121-1030), 25 ul Illumina Tagment DNA buffer (TD, Nextera® DNA Sample Preparation Kit cat# FC-121-1030), and 22.5 ul of nuclease free water and incubated at 37°C for 30 min under gentle mixing condition (300 rpm). The transposed and adapter-ligated DNA fragments were purified using a Qiagen MinElute PCR Purification Kit The purified DNA was PCR amplified using barcoded primers (Nextera Index Kit, FC-121-1011) for 12 cycles: [72°C for 5 min, 98°C for 30 sec (98°C for 10 sec, 63°C for 30 sec, 72°C for 1 min) x 12]. Agencourt AMPure XP beads (Beckman Coulter) were used for size-selection of >150bp DNA fragments.

Platform

PlatformILLUMINA
Instrument ModelIllumina HiSeq 2500

Processing

Base Calls
Sequence Space
Base Caller

Spot Information

Number of Reads per Spots0
Spot Length0

Read Spec

Navigation

Submission ERA1837514 FTP
Study ERP114841
Sample ERS3370481
Run ERR3281598 FASTQ SRA
Website policy | © DNA Data Bank of Japan